Investors: Press Releases

Press Releases

March 10, 2022
NexImmune to Present at the Barclays 2022 Global Healthcare Conference
March 9, 2022
NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
February 17, 2022
NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors
February 1, 2022
NexImmune Announces Research Collaboration with Rutgers, The State University of New Jersey, Related to Neuroendocrine Tumor Targets
January 18, 2022
NexImmune to Participate in The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP) Panel on “Expanding the Possible with Next-Generation Cell Therapies” 
January 5, 2022
NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
December 12, 2021
NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
November 12, 2021
NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates
November 8, 2021
NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November 12, 2021
November 3, 2021
NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting
Displaying 11 - 20 of 57